Citius Pharmaceuticals, Inc. (CTXR)
| Market Cap | 214.66M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -24.51M |
| Shares Out | 146.03M |
| EPS (ttm) | -0.23 |
| PE Ratio | n/a |
| Forward PE | 1.29 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,244,497 |
| Open | 1.55 |
| Previous Close | 1.55 |
| Day's Range | 1.45 - 1.56 |
| 52-Week Range | 1.15 - 4.56 |
| Beta | 1.45 |
| Analysts | Buy |
| Price Target | 6.67 (+353.7%) |
| Earnings Date | n/a |
About CTXR
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections followin...
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for CTXR stock is "Buy" and the 12-month stock price forecast is 6.67.
News
Citius Pharmaceuticals, Inc. to Present at Upcoming Virtual Conferences
CRANFORD, N.J., Jan. 4, 2022 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercializ...
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2021 Financial Results and Provides Business Update
CRANFORD, N.J., Dec. 15, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commerciali...
Citius Pharmaceuticals Completes Enrollment in the Pivotal Phase 3 Study of its Cancer Immunotherapy I/ONTAK for the ...
CRANFORD, N.J., Dec. 6, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercializ...
Citius Pharmaceuticals Expands Management Team with Appointment of Kelly Creighton, PhD as Executive Vice President o...
CRANFORD, N.J., Nov. 5, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercializ...
Citius Pharmaceuticals to Host Key Opinion Leader Webcast on the Compelling Need to Salvage Central Venous Catheters ...
CRANFORD, N.J., Oct. 25, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commerciali...
Top Penny Stocks to Add to Your Watchlist This Week
Which penny stocks are on your watchlist for this coming week? The post Top Penny Stocks to Add to Your Watchlist This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStoc...
Citius Pharmaceuticals to Host Investor Webcast to Discuss the Acquisition of Late Phase 3 Cancer Immunotherapy I/ONT...
CRANFORD, N.J., Oct. 13, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced that it will host a webcast on October 20, 2021 at 8:30 a.m.
Citius Pharmaceuticals to Present at Upcoming October Investor Conferences
CRANFORD, N.J., Oct. 6, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercializ...
Temple University Renames College of Liberal Arts Main Campus Building in Honor of Citius Pharmaceuticals Executive C...
CRANFORD, N.J., Oct. 1, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercializ...
Citius Pharmaceuticals to Join Benzinga All Access Show on Friday, September 17, 2021
CRANFORD, N.J., Sept. 14, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of ...
Citius Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15
CRANFORD, N.J., Sept. 8, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of f...
Citius Pharmaceuticals Acquires Dr. Reddy's Laboratories' License for Late-Phase 3 Oncology Immunotherapy (E7777) for...
CRANFORD, N.J., Sept. 7, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced that it has entered into a definitive agreement with Dr. Reddy's Lab...
Best Penny Stocks For Your Buy List in September? 3 To Watch
With September only a day away, which penny stocks are on your buy list? The post Best Penny Stocks For Your Buy List in September?
Citius Pharmaceuticals, Inc. Reports Third Fiscal Quarter 2021 Financial Results and Provides General Business Update
CRANFORD, N.J., Aug. 12, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of f...
Citius Pharmaceuticals Addresses Unmet Needs for Patients with CVCs
Image by falco from Pixabay What happens when the one product keeping you alive becomes infected?
Best Reddit Penny Stocks to Buy in August? 3 For Your List
There's a reason that so many investors like Reddit penny stocks; here's 3 for your list The post Best Reddit Penny Stocks to Buy in August? 3 For Your List appeared first on Penny Stocks to Buy, Picks,...
Could Citius Pharmaceuticals Be a Millionaire-Maker Stock?
A lot would have to go right for this biotech to make investors rich.
3 Penny Stocks That Are Popular With Reddit Traders Right Now
These Reddit Penny Stocks Are Rising in Popularity Right Now; Are They Worth It or Not? The post 3 Penny Stocks That Are Popular With Reddit Traders Right Now appeared first on Penny Stocks to Buy, Pick...
7 Top-Rated Pharmaceutical Companies to Invest In for July
Pharma stocks like MNMD stock and ANVS stock offer investors long-term growth potential in a market on track to hit a value of $1.70 trillion. The post 7 Top-Rated Pharmaceutical Companies to Invest In ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Citius Pharmaceuticals, Inc. - CTXR
NEW YORK, July 7, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Citius Pharmaceuticals, Inc. ("Citrus" or the "Company") (NASDAQ: CTXR). Such investors are advise...
Citius Pharmaceuticals, Inc. Provides First Half 2021 Business Update, Highlights Upcoming Milestones
CRANFORD, N.J., July 7, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of fi...
Are Options Traders Betting on a Big Move in Citius Pharmaceuticals (CTXR) Stock?
Investors need to pay close attention to Citius Pharmaceuticals (CTXR) stock based on the movements in the options market lately.
Here's Why Citius Pharmaceuticals Stock Is Losing Ground Today
Another interim analysis has come and gone with an unsatisfying result.
Citius Pharmaceuticals, Inc. Announces Positive Recommendation by Independent Data Monitoring Committee to Continue t...
CRANFORD, N.J., July 1, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of fi...